Enovis Bullish on Second Half Despite Tougher Comps
The company grew in the mid-teens for the second quarter of 2023 and raised full-year guidance despite tougher comps in...
The company grew in the mid-teens for the second quarter of 2023 and raised full-year guidance despite tougher comps in...
The company grew in the mid-single-digits on a pro forma basis for the second quarter of 2023 as it embarks...
FDA approved a smaller height of Mobi-C in seven footprints to address the anatomical needs of the U.S. patient population....
ZuriMED will accelerate activities supporting Surgical-Fiberlock technology for minimally invasive surgical repair of soft tissues....
The company grew in the double-digits for the second quarter of 2023 as it hit records for both total sales...
Exactech's Chief Strategy Officer and Chief Medical Officer takes his insight on hip resurfacing from the operating room to the...
The company grew in the mid-single digits for 2Q23 as improving operational execution allowed it to leverage elevated orthopedic volumes....
The company grew nearly 40% in the second quarter of 2023 on the strength of its spine focus and lateral...
The company grew in the low single digits for the second quarter of 2023 but remains on track to achieve...
The company grew in the high single digits for the second quarter of 2023 on the strength of its joint...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.